MetLife Investment Management, LLC - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 133 filers reported holding ANAPTYSBIO INC in Q3 2020. The put-call ratio across all filers is 62.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$198,332
-11.7%
11,0430.0%0.00%0.0%
Q2 2023$224,615
-6.5%
11,0430.0%0.00%0.0%
Q1 2023$240,296
-29.8%
11,0430.0%0.00%
-33.3%
Q4 2022$342,223
+21.5%
11,0430.0%0.00%
+50.0%
Q3 2022$281,707
+25.7%
11,0430.0%0.00%0.0%
Q2 2022$224,173
-17.9%
11,0430.0%0.00%0.0%
Q1 2022$273,204
+11.8%
11,043
+57.0%
0.00%0.0%
Q4 2021$244,432
+28.1%
7,0340.0%0.00%0.0%
Q3 2021$190,762
-34.7%
7,034
-37.6%
0.00%
-33.3%
Q2 2021$292,257
+20.3%
11,2710.0%0.00%
+50.0%
Q1 2021$242,890
+0.2%
11,2710.0%0.00%0.0%
Q4 2020$242,327
+45.8%
11,2710.0%0.00%0.0%
Q3 2020$166,247
-34.0%
11,2710.0%0.00%
-33.3%
Q2 2020$251,794
+58.1%
11,2710.0%0.00%
+50.0%
Q1 2020$159,259
-13.0%
11,2710.0%0.00%0.0%
Q4 2019$183,154
-53.6%
11,2710.0%0.00%
-60.0%
Q3 2019$394,372
-38.0%
11,2710.0%0.01%
-28.6%
Q2 2019$635,908
-8.2%
11,271
+18.9%
0.01%
-12.5%
Q1 2019$692,660
+14.5%
9,4820.0%0.01%0.0%
Q4 2018$604,857
-26.4%
9,482
+15.1%
0.01%
-11.1%
Q3 2018$822,005
+40.5%
8,2390.0%0.01%
+28.6%
Q2 2018$585,000
-31.8%
8,2390.0%0.01%
-30.0%
Q1 2018$858,000
+3.4%
8,2390.0%0.01%
+11.1%
Q4 2017$830,0008,2390.01%
Other shareholders
ANAPTYSBIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,316,447$169,216,00040.73%
Cormorant Asset Management, LP 920,000$67,206,0004.54%
Ghost Tree Capital, LLC 115,000$8,401,0002.20%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 743,439$54,308,0002.08%
BVF INC/IL 220,265$16,090,0001.80%
Redmile Group, LLC 496,918$36,300,0001.06%
Sofinnova Investments, Inc. 97,948$7,155,0000.69%
Opus Point Partners Management, LLC 6,116$447,0000.61%
ADAGE CAPITAL PARTNERS GP, L.L.C. 2,673,784$195,320,0000.49%
Rock Springs Capital Management LP 170,000$12,419,0000.48%
View complete list of ANAPTYSBIO INC shareholders